Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.47 - $10.36 $413,838 - $573,944
-55,400 Reduced 86.7%
8,500 $67,000
Q2 2024

Aug 14, 2024

SELL
$8.25 - $11.29 $212,850 - $291,282
-25,800 Reduced 28.76%
63,900 $569,000
Q1 2024

May 15, 2024

BUY
$7.86 - $11.65 $705,042 - $1.05 Million
89,700 New
89,700 $1.05 Million
Q3 2023

Nov 14, 2023

BUY
$11.23 - $14.43 $120,161 - $154,401
10,700 Added 194.55%
16,200 $182,000
Q2 2023

Aug 14, 2023

BUY
$10.76 - $13.91 $40,888 - $52,858
3,800 Added 223.53%
5,500 $63,000
Q1 2023

May 15, 2023

SELL
$12.6 - $16.02 $77,490 - $98,523
-6,150 Reduced 78.34%
1,700 $23,000
Q4 2022

Feb 14, 2023

BUY
$12.26 - $14.6 $96,241 - $114,610
7,850 New
7,850 $103,000

Others Institutions Holding EHAB

About Enhabit, Inc.


  • Ticker EHAB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 49,618,400
  • Market Cap $381M
  • Description
  • Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and condi...
More about EHAB
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.